A broad range of top-rated stocks hit new highs Tuesday even as the market ended mixed. Stocks in the pharmaceuticals, transportation and software industries turned in some of the strongest performances. Regeneron Pharmaceuticals (REGN) rose 9.05, or 3% to 359.50, after results of its phase-three trial of cholesterol drug alirocumab showed reduced risk of heart attack and stroke.